Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C, Shehzad K, Morath V, Spellerberg R, Ranke J, Steiger K, Kälin RE, Multhoff G, Eiber M, Schilling F, Glass R, Weber WA, Wagner E, Nelson PJ, Spitzweg C. Kitzberger C, et al. Mol Ther Oncolytics. 2023 Aug 15;30:238-253. doi: 10.1016/j.omto.2023.08.004. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37701849 Free PMC article.
An unusual case of struma ovarii.
Koehler VF, Keller P, Waldmann E, Schwenk N, Kitzberger C, Schmohl KA, Knösel T, Stief CG, Spitzweg C. Koehler VF, et al. Among authors: kitzberger c. Endocrinol Diabetes Metab Case Rep. 2021 Mar 5;2021:20-0142. doi: 10.1530/EDM-20-0142. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2021. PMID: 33682680 Free PMC article.
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.
Spellerberg R, Benli-Hoppe T, Kitzberger C, Hageneier M, Schwenk N, Öztürk Ö, Steiger K, Multhoff G, Eiber M, Schilling F, Weber WA, Kälin RE, Glass R, Nelson PJ, Wagner E, Spitzweg C. Spellerberg R, et al. Among authors: kitzberger c. Mol Ther Oncolytics. 2022 Nov 3;27:272-287. doi: 10.1016/j.omto.2022.10.013. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36458201 Free PMC article.
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.
Spellerberg R, Benli-Hoppe T, Kitzberger C, Berger S, Schmohl KA, Schwenk N, Yen HY, Zach C, Schilling F, Weber WA, Kälin RE, Glass R, Nelson PJ, Wagner E, Spitzweg C. Spellerberg R, et al. Among authors: kitzberger c. Mol Ther Oncolytics. 2021 Oct 30;23:432-446. doi: 10.1016/j.omto.2021.10.011. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34853814 Free PMC article.
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy.
Tutter M, Schug C, Schmohl KA, Urnauer S, Kitzberger C, Schwenk N, Petrini M, Zach C, Ziegler S, Bartenstein P, Weber WA, Multhoff G, Wagner E, Lindner LH, Nelson PJ, Spitzweg C. Tutter M, et al. Among authors: kitzberger c. Mol Ther. 2021 Feb 3;29(2):788-803. doi: 10.1016/j.ymthe.2020.10.009. Epub 2020 Oct 15. Mol Ther. 2021. PMID: 33068779 Free PMC article.
Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy.
Schug C, Kitzberger C, Sievert W, Spellerberg R, Tutter M, Schmohl KA, Eberlein B, Biedermann T, Steiger K, Zach C, Schwaiger M, Multhoff G, Wagner E, Nelson PJ, Spitzweg C. Schug C, et al. Among authors: kitzberger c. Clin Cancer Res. 2019 Oct 1;25(19):5997-6008. doi: 10.1158/1078-0432.CCR-18-4092. Epub 2019 Jun 13. Clin Cancer Res. 2019. PMID: 31196853